Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 11Gastrointestinal 11Genitourinary 8Thoracic 3Breast 3Dermatologic 1

Conditions

Breast Neoplasms 3Radiation Injuries 1

Interventions

Trastuzumab 692Paclitaxel 678Cyclophosphamide 634Docetaxel 553Capecitabine 467Letrozole 407Carboplatin 392Fulvestrant 377Doxorubicin 330Tamoxifen 288pembrolizumab 270Anastrozole 252Epirubicin 249exemestane 238pertuzumab 226Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Lymph Node Excision × Breast × Clear all
NCT04889924 2026-05-19

ADARNAT

Hospital Universitari de Bellvitge

Phase NA Recruiting
820 enrolled
Breast

Breast Neoplasms, Radiation Injuries

NCT04865549 2021-04-29

SANA

Hospital Clinic of Barcelona

Phase NA Completed
90 enrolled
Breast

Breast Neoplasms

NCT01880645 2015-11-18

Selective Image Guided Resection of Axillary Lymph Nodes

M.D. Anderson Cancer Center

Phase NA Completed
17 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡